Mga Batayang Estadistika
| CIK | 918112 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Neurobiological Technologies, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| January 3, 2019 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2018 NEUROBIOLOGICAL TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 000-23280 94-3049219 (State or other Jurisdiction of Incorpora |
|
| December 23, 2015 |
Neurobiological Technologies FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2015 NEUROBIOLOGICAL TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 000-23280 94-3049219 (State or other Jurisdiction of Inco |
|
| December 17, 2012 |
Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2012 NEUROBIOLOGICAL TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 000-23280 94-3049219 (State or other Jurisdiction of Inco |
|
| December 17, 2012 |
Neurobiological Technologies Announces Dividend of $0.05 per share Exhibit 99.1 Neurobiological Technologies Announces Dividend of $0.05 per share San Ramon, CA, December 17, 2012 – Neurobiological Technologies, Inc. (OTC Markets: NTII) (NTI or the Company) announced today that its board of directors has declared an extraordinary dividend of $0.05 per share of common stock, which will be paid on December 27, 2012 to stockholders of record as of December 20, 2012. |
